GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Cirrhosis Liver/VOCAL-Penn score

VOCAL-Penn score

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated December 1, 2025

Quick Answer

The VOCAL-Penn score (VPS) is a medical risk prediction tool developed in 2021 to estimate postoperative mortality and decompensation risk in patients with cirrhosis undergoing surgical procedures. It is widely adopted in clinical practice, with over 15,000 users annually, and has been incorporated into major national and international society guidelines.


The VOCAL-Penn score (VPS) is a medical risk prediction tool developed in 2021 to estimate postoperative mortality and decompensation risk in patients with cirrhosis undergoing surgical procedures. It is widely adopted in clinical practice, with over 15,000 users annually, and has been incorporated into major national and international society guidelines.

### Key Features of the VOCAL-Penn Score:

1. **Purpose**: The VPS helps clinicians assess the risks associated with surgery in patients with cirrhosis, a population that often faces higher surgical risks due to their complex medical condition.

2. **Clinical Use**: The tool is designed to support surgical decision-making by providing accurate predictions of postoperative outcomes, enabling clinicians to better stratify risk and guide treatment plans.

3. **Adoption**: Since its introduction, the VPS has achieved significant real-world uptake, indicating its utility and credibility among healthcare providers.

### Factors Supporting Its Adoption:

The VOCAL-Penn score has been successful due to its alignment with five key design and implementation factors identified through clinician feedback:

1. **Efficiency**: The tool is intuitive, requires minimal inputs, and integrates seamlessly into clinical workflows.

2. **Accessibility**: Input variables are clinically meaningful and readily available, making the tool easy to use in practice.

3. **Transparency**: The development process of the VPS is transparent, fostering trust among clinicians.

4. **Accuracy**: Comparative performance data and external validations ensure the tool’s credibility and reliability.

5. **Generalizability**: The score is applicable across diverse patient populations, supporting equitable use.

### Context of Development:

The VPS was developed during a time when advancements in data science, electronic health records, and machine learning were driving the proliferation of medical prediction tools. Despite the availability of such tools, many faced challenges in achieving sustained clinical adoption due to usability and implementation issues. The VPS stands out as an example of a prediction model that successfully bridges the gap between statistical rigor and practical usability.

### Research Insights:

A qualitative study involving 22 diverse clinicians who care for cirrhosis patients highlighted the importance of aligning risk prediction tools like the VPS with real-world clinical needs. Clinicians emphasized that tools should be easy to use, credible, and seamlessly integrated into existing workflows to encourage adoption.

### Conclusion:

The VOCAL-Penn score serves as a model for designing effective medical risk prediction tools. By addressing practical factors such as efficiency, accessibility, transparency, accuracy, and generalizability, the VPS has achieved widespread use and has provided valuable insights for developing future tools. Its success demonstrates the importance of considering both statistical performance and real-world implementation needs in the design of clinical prediction models.

Related Q&A

POCUS-Guided AKI Management in Cirrhosis: Hepatology | July 2026

Introduction: Acute kidney injury (AKI) is a frequent and life-threatening complication of cirrhosis, with management often complicated by inaccurate assessment of intravascular volume and the presence of cirrhotic cardiomyopathy (CCM). This prospective study evaluated whether...

A Novel Pro-Resolving Target (Annexin A1) for ACLF: Hepatology | May 2026

Introduction: Acute-on-chronic liver failure (ACLF) is characterized by overwhelming systemic inflammation and immune dysregulation, leading to high short-term mortality. This study used advanced single-cell and spatial transcriptomic technologies to define the immune landscape of ACLF...

Distal Esophageal Varices in Fontan Circulation: Hepatology | May 2026

Introduction: Adults with Fontan-type circulation are increasingly recognized to develop Fontan-associated liver disease and portal hypertension. This prospective study explored the prevalence, anatomical distribution, and hemodynamic characteristics of esophageal varices (EV), with particular emphasis on...

Annexin A1-A Novel Pro-Resolving Target for ACLF: Hepatology | May 2026

Introduction: Acute-on-chronic liver failure (ACLF) is characterized by overwhelming systemic inflammation and immune dysregulation, leading to high short-term mortality. This study used advanced single-cell and spatial transcriptomic technologies to define the immune landscape of ACLF...

Simvastatin Improves Survival After Variceal Bleeding in Cirrhosis: AJG | July 2026

Introduction: Despite advances in the management of portal hypertension, mortality after variceal bleeding remains high in patients with cirrhosis. Experimental and clinical studies suggest that statins may improve portal hypertension and hepatic vascular function. This...

Pre-Emptive CRRT Improves Outcomes in ALF with Cerebral Oedema: AP&T | June 2026

Introduction: Acute liver failure (ALF) complicated by cerebral oedema carries a high risk of early mortality, primarily due to hyperammonemia and intracranial hypertension. The optimal timing of continuous renal replacement therapy (CRRT) in these critically...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer